Original
Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica
Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia
Luis Felipe Casadoa, José Antonio García Marcob, Florinda Gilsanzc, Marcos Gonzálezd, Eduardo Ríose, Javier de la Sernac, Álvaro Urbanof, Vicente Vicenteg, Carlos Rubio-Terrésh, Antonio J. Castroi,
Corresponding author
a Hospital Virgen de la Salud, Toledo, España
b Hospital Universitario Puerta Hierro, Madrid, España
c Hospital Universitario 12 de Octubre, Madrid, España
d Hospital Clínico Universitario, Salamanca, España
e Hospital Universitario Nuestra Señora de Valme, Sevilla, España
f Hospital Universitario Virgen del Rocío, Sevilla, España
g Hospital General Universitario, Murcia, España
h Health Value, Madrid, España
i Roche Farma, Madrid, España
Ver másRead
1432
Timeswas read the article
441
Total PDF
991
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 37 | 26 | 63 |
| 2024 October | 79 | 41 | 120 |
| 2024 September | 85 | 28 | 113 |
| 2024 August | 87 | 32 | 119 |
| 2024 July | 55 | 28 | 83 |
| 2024 June | 56 | 13 | 69 |
| 2024 May | 50 | 27 | 77 |
| 2024 April | 56 | 18 | 74 |
| 2024 March | 85 | 34 | 119 |
| 2024 February | 48 | 29 | 77 |
| 2024 January | 48 | 17 | 65 |
| 2023 December | 43 | 19 | 62 |
| 2023 November | 40 | 21 | 61 |
| 2023 October | 36 | 18 | 54 |
| 2023 September | 34 | 25 | 59 |
| 2023 August | 37 | 14 | 51 |
| 2023 July | 62 | 22 | 84 |
| 2023 June | 32 | 15 | 47 |
| 2023 May | 21 | 14 | 35 |
Show all
